News & Media

Press Releases

Amolyt Pharma to Present New Phase 1 Data on AZP-3601, its Parathyroid Hormone Analog for Hypoparathyroidism, and Preclinical Data on AZP-3404 at Upcoming Scientific Conferences

Download a PDF copy of this press release: EN FR New data from all cohorts of Phase 1 Single Ascending Dose clinical trial accepted for …

Download a PDF: EN or FR

Amolyt Pharma Presents First Clinical Data for AZP-3601, its Parathyroid Hormone Analog for Hypoparathyroidism, at the Endocrine Society’s Virtual Annual Meeting (ENDO 2021)

Download a PDF copy of this press release: EN FR Data from first 4 cohorts of the single ascending dose (SAD) study show that AZP-3601 …

Download a PDF: EN or FR

Amolyt Pharma to Present Preliminary Phase 1 Data on AZP-3601 for Hypoparathyroidism and Additional Preclinical Data on AZP-3404 at ENDO 2021

Download a PDF copy of this press release: EN FR Four abstracts accepted as poster presentations for the Endocrine Society’s Annual Meeting LYON, France, and …

Download a PDF: EN or FR

Upcoming events

Date: September 29 – October 3, 2021 (Virtual)

Learn more about the conference »

Date: October 2021

Date: October 1-4, 2021 (Toronto)

Learn more about the conference »

Date: October 13-16, 2021 (Le Havre)

Learn more about the conference »

Date: October 19-22, 2021 (Denver, CO)

Learn more about the conference »

Date: November 2-7, 2021 (San Diego, CA)

Learn more about the conference »

Date: November 1, 2021

Social Updates

TWITTER

Scroll to Top